BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 32814342)

  • 1. Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms.
    Billesbølle CB; Azumaya CM; Kretsch RC; Powers AS; Gonen S; Schneider S; Arvedson T; Dror RO; Cheng Y; Manglik A
    Nature; 2020 Oct; 586(7831):807-811. PubMed ID: 32814342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of ion transport and inhibition in ferroportin.
    Pan Y; Ren Z; Gao S; Shen J; Wang L; Xu Z; Yu Y; Bachina P; Zhang H; Fan X; Laganowsky A; Yan N; Zhou M
    Nat Commun; 2020 Nov; 11(1):5686. PubMed ID: 33173040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional properties of human ferroportin, a cellular iron exporter reactive also with cobalt and zinc.
    Mitchell CJ; Shawki A; Ganz T; Nemeth E; Mackenzie B
    Am J Physiol Cell Physiol; 2014 Mar; 306(5):C450-9. PubMed ID: 24304836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis.
    Nemeth E; Ganz T
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ironing out Ferroportin.
    Drakesmith H; Nemeth E; Ganz T
    Cell Metab; 2015 Nov; 22(5):777-87. PubMed ID: 26437604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular catabolism of the iron-regulatory peptide hormone hepcidin.
    Preza GC; Pinon R; Ganz T; Nemeth E
    PLoS One; 2013; 8(3):e58934. PubMed ID: 23536837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin.
    Aschemeyer S; Qiao B; Stefanova D; Valore EV; Sek AC; Ruwe TA; Vieth KR; Jung G; Casu C; Rivella S; Jormakka M; Mackenzie B; Ganz T; Nemeth E
    Blood; 2018 Feb; 131(8):899-910. PubMed ID: 29237594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepcidin-binding site on ferroportin is evolutionarily conserved.
    De Domenico I; Nemeth E; Nelson JM; Phillips JD; Ajioka RS; Kay MS; Kushner JP; Ganz T; Ward DM; Kaplan J
    Cell Metab; 2008 Aug; 8(2):146-56. PubMed ID: 18680715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutation.
    Wallace DF; McDonald CJ; Ostini L; Iser D; Tuckfield A; Subramaniam VN
    Am J Hematol; 2017 Oct; 92(10):1052-1061. PubMed ID: 28681497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of ferroportin in complex with its specific inhibitor vamifeport.
    Lehmann EF; Liziczai M; Drożdżyk K; Altermatt P; Langini C; Manolova V; Sundstrom H; Dürrenberger F; Dutzler R; Manatschal C
    Elife; 2023 Mar; 12():. PubMed ID: 36943194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outward- and inward-facing structures of a putative bacterial transition-metal transporter with homology to ferroportin.
    Taniguchi R; Kato HE; Font J; Deshpande CN; Wada M; Ito K; Ishitani R; Jormakka M; Nureki O
    Nat Commun; 2015 Oct; 6():8545. PubMed ID: 26461048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepcidin-ferroportin axis in health and disease.
    Ginzburg YZ
    Vitam Horm; 2019; 110():17-45. PubMed ID: 30798811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Guanosine 5'-diphosphate as Potential Iron Mobilizer: Preventing the Hepcidin-Ferroportin Interaction and Modulating the Interleukin-6/Stat-3 Pathway.
    Angmo S; Tripathi N; Abbat S; Sharma S; Singh SS; Halder A; Yadav K; Shukla G; Sandhir R; Rishi V; Bharatam PV; Yadav H; Singhal NK
    Sci Rep; 2017 Jan; 7():40097. PubMed ID: 28054602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology of the iron efflux transporter, ferroportin.
    Rishi G; Subramaniam VN
    Adv Protein Chem Struct Biol; 2021; 123():1-16. PubMed ID: 33485480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An essential cell-autonomous role for hepcidin in cardiac iron homeostasis.
    Lakhal-Littleton S; Wolna M; Chung YJ; Christian HC; Heather LC; Brescia M; Ball V; Diaz R; Santos A; Biggs D; Clarke K; Davies B; Robbins PA
    Elife; 2016 Nov; 5():. PubMed ID: 27897970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UBA6 and NDFIP1 regulate the degradation of ferroportin.
    Traeger L; Wiegand SB; Sauer AJ; Corman BHP; Peneyra KM; Wunderer F; Fischbach A; Bagchi A; Malhotra R; Zapol WM; Bloch DB
    Haematologica; 2022 Feb; 107(2):478-488. PubMed ID: 34320783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepcidin and ferroportin: the new players in iron metabolism.
    De Domenico I; Ward DM; Kaplan J
    Semin Liver Dis; 2011 Aug; 31(3):272-9. PubMed ID: 21901657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.
    Nemeth E; Tuttle MS; Powelson J; Vaughn MB; Donovan A; Ward DM; Ganz T; Kaplan J
    Science; 2004 Dec; 306(5704):2090-3. PubMed ID: 15514116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload.
    Altamura S; Kessler R; Gröne HJ; Gretz N; Hentze MW; Galy B; Muckenthaler MU
    Cell Metab; 2014 Aug; 20(2):359-67. PubMed ID: 25100063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2.
    De Domenico I; Lo E; Ward DM; Kaplan J
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3800-5. PubMed ID: 19234114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.